Table 4.
Predictors of Higher Treatment Costs.
| Ref. | Variables | Incremental cost in 2020 USD |
|---|---|---|
| Age | ||
| 31 | continuous | 142$ (41-243) |
| 32 | > 70 | 2,532$ (751-4,630) |
| Gender | ||
| 32 | Female | 1,252$ (119-2,243) |
| 41 | Female | −1285.2 |
| 31 | Neurological level cervical | 11,327$ (7,484-15,170) |
| 37 | Charlson Index | 2,979$ (833-5,724) |
| 31 | Injury Severity Score | 582$ (385-780) |
| 31 | ASIA grade | |
| A | 9,865$ (4,851-14,878) | |
| B | 11,764$ (6,538-16,991) | |
| C | 4,419$ (−939-9777) | |
| D | 0 | |
| 32 | Traumatic brain injury | 1,805$ (233-5,778) |
| 37 | Additional injury | |
| one | 6,300 | |
| 2 or more | 27,524 | |
| 34 | Care pathway; | |
| admission to SCI center ≥24 h | 6,093$ (1,370-10,816) | |
| 31 | Surgical delay | |
| Continuous | 17.8$ (6.1-29.3) | |
| > 24 h | 6,300$ (10,460-2,140) | |
| 32 | Complication development | 4,995$ (108-9,881) |
| 34 | 6,518$ (4,525-8,801) | |
| 41 | Accreditation | |
| Medical centers | 3,681.1 | |
| Community hospitals | −312.5 |
* Statistically significant factors associated with an increase/decrease in.
Costs that were identified by a multiple regression analysis.